phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

Measles was declared eliminated in the United States in 2000, thanks to widespread vaccination with the MMR vaccine. Unfortunately, in recent weeks, there has been an alarming increase in measles cases across the country – from Texas and New Mexico to New York and Rhode Island and the first reported death in a decade.

Here are several things to know about measles and the MMR vaccine, which is recommended for all babies and young children.

Measles is a highly contagious and life-threatening virus.

  • Before vaccines were available starting in the 1960s, there were 3 to 4 million cases of measles annually. Over 90% of children would contract the measles virus by the age of 15. This led to 400 to 500 deaths per year plus the potential for long-term complications and disability for some people.
  • Measles symptoms early on include fever, cough, runny nose and red eyes. A distinctive rash appears roughly 3-5 days after onset of symptoms. Long term complications can include respiratory complications (like bacterial pneumonia) and, in some cases, brain swelling and inflammation (called encephalitis). These complications can ultimately lead to death.
  • In 2023, 107,500 people globally died from measles, most of whom were unvaccinated or under-vaccinated children under the age of five.

    Vaccines are safe, effective and necessary to prevent measles.

    • Measles is one of the most contagious infections in the world. People without prior immunity are 90% likely to contract measles if they were exposed in close-contact settings. What’s more, the measles virus can remain in the air for up to two hours after an infected person leaves a space.
    • One dose of the MMR vaccine is 93% effective at preventing measles, and a second dose increases its effectiveness to 97%. It is recommended that children receive two doses.
    • Vaccines are also subject to a rigorous safety and efficacy testing and review prior to approval and are closely monitored after approval. Thanks to data from this testing and studies by independent researchers, there is overwhelming evidence that the MMR vaccine is safe.

    Vaccines highlight the biopharmaceutical industry’s commitment to disease prevention – not just treatment.

    • In the United States alone, 21 diseases are now preventable due to childhood vaccines, preventing an estimated 508 million illnesses, 32 million hospitalizations and over 1.1 million deaths among children born between 1994 and 2023. This includes polio prevention, which has been hailed a significant public health victory.
    • Biopharmaceutical companies invest heavily in vaccine research and development to create a brighter future, and many vaccines in the pipeline are using new technologies that could help prevent the spread of HIV, protect against malaria and treat or prevent several types of cancer, Alzheimer’s disease and allergies.

    I often think of the young cancer patients that I care for in the emergency department, who are immune suppressed from chemotherapy, and how they need the collective action of all Americans to be vaccinated in order to be protected while they fight cancer. We have the necessary tool - a highly effective MMR vaccine – to safely stop this measles outbreak in its tracks – and we must use it.

    This is why we encourage you to consult your health care provider to ensure you and your children are up to date on recommended vaccines, including MMR.

    Mike Ybarra

    Michael Ybarra, M.D., is an emergency physician and Chief Medical Officer at PhRMA. He also serves as Senior Vice President in Advocacy and Strategic Alliances. In these roles, he leads PhRMA’s stakeholder engagement and strategic partnerships on federal and international health policy issues. He is PhRMA’s liaison representative to the Advisory Committee on Immunization Practices and is the co-convener of PhRMA’s R&D Leadership Forum. Dr. Ybarra continues to see patients clinically in the emergency department at MedStar Georgetown University Hospital.

    Follow Mike on LinkedIn and X.

    Mike Ybarra

    Why smart vaccine policy matters

    August 3, 2026

    New study: HPV vaccination helps prevent cervical cancer deaths

    July 21, 2026

    New research reinforces the importance of hepatitis B vaccination at birth

    May 21, 2026

    World Immunization Week: Putting preventable diseases in the past

    April 24, 2026

    Father holding child on his shoulders

    Vaccines

    Infectious Diseases

    What you need to know: Measles and the MMR vaccine

    March 10, 2025

    Father holding child on his shoulders

    Stay current on policy making

    Sign up for email updates and follow us on social. 

    About

    Our Agenda

    Policy Issues

    Resources

    Blog

    Contact Us

    Privacy Policy

    Terms of Service

    Facebook

    Facebook

    X

    Twitter X

    LinkedIn

    LinkedIn

    Instagram

    instagram logo

    America's Medicines

    PhRMA Foundation

    Voters for Cures

    Working for Cures

    Innovation.org

    Please type your email

    Success!

    You've been added to the list